Sabine Turri
Rueil-malmaison, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 03, 2023
Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.
Journal: Therapeutic innovation & regulatory science
Published: April 01, 2021
Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.
Journal: Therapeutic innovation & regulatory science
Published: February 07, 2020
Corrigendum to 'Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer' [European Journal of Cancer 76 (2017) 36-44].
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2017
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 07, 2017
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 10, 2017
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Journal: The Lancet. Oncology
Published: September 01, 2016
A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours.
Journal: Anticancer research
Published: February 07, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026